Connection

David Cole to Lymphatic Metastasis

Back to Details
This is a "connection" page, showing publications David Cole has written about Lymphatic Metastasis.
David Cole
Connection Strength
0.600
Lymphatic Metastasis
  1. Detection of occult breast cancer micrometastases in axillary lymph nodes using a multimarker reverse transcriptase-polymerase chain reaction panel. J Am Coll Surg. 1998 Jul; 187(1):9-16.
    View in: PubMed
    Score: 0.141
  2. The impact of lymph node disease in extremity soft-tissue sarcomas: a population-based analysis. Am J Surg. 2013 Sep; 206(3):289-95.
    View in: PubMed
    Score: 0.100
  3. A quantitative reverse transcription-PCR assay for rapid, automated analysis of breast cancer sentinel lymph nodes. J Mol Diagn. 2009 Nov; 11(6):576-82.
    View in: PubMed
    Score: 0.077
  4. The molecular detection of micrometastatic breast cancer. Am J Surg. 2003 Oct; 186(4):351-8.
    View in: PubMed
    Score: 0.051
  5. Quantitative real-time RT-PCR detection of breast cancer micrometastasis using a multigene marker panel. Int J Cancer. 2001 Jul 15; 93(2):162-71.
    View in: PubMed
    Score: 0.044
  6. Surgical management of patients with intermediate thickness melanoma: current role of elective lymph node dissection. Semin Oncol. 1996 Dec; 23(6):719-24.
    View in: PubMed
    Score: 0.032
  7. Melanoma of the external ear. J Surg Oncol. 1992 Jun; 50(2):110-4.
    View in: PubMed
    Score: 0.023
  8. The role of sentinel lymph node biopsy in select sarcoma patients: a meta-analysis. Am J Surg. 2012 Oct; 204(4):428-33.
    View in: PubMed
    Score: 0.023
  9. Molecular detection of micrometastatic breast cancer in histopathology-negative axillary lymph nodes fails to predict breast cancer recurrence: a final analysis of a prospective multi-institutional cohort study. Ann Surg Oncol. 2010 Oct; 17 Suppl 3:312-20.
    View in: PubMed
    Score: 0.021
  10. A rapid, fully automated, molecular-based assay accurately analyzes sentinel lymph nodes for the presence of metastatic breast cancer. Ann Surg. 2006 Mar; 243(3):389-98.
    View in: PubMed
    Score: 0.015
  11. Molecular analysis improves sensitivity of breast sentinel lymph node biopsy: results of a multi-institutional prospective cohort study. Surgery. 2005 Sep; 138(3):474-81.
    View in: PubMed
    Score: 0.014
  12. An innovative microarray strategy identities informative molecular markers for the detection of micrometastatic breast cancer. Clin Cancer Res. 2005 May 15; 11(10):3697-704.
    View in: PubMed
    Score: 0.014
  13. EpCAM is overexpressed in breast cancer and is a potential target for breast cancer gene therapy. Cancer Res. 2004 Aug 15; 64(16):5818-24.
    View in: PubMed
    Score: 0.013
  14. Real-time reverse transcription-PCR detects KS1/4 mRNA in mediastinal lymph nodes from patients with non-small cell lung cancer. Clin Chem. 2003 Feb; 49(2):312-5.
    View in: PubMed
    Score: 0.012
  15. Melanoma thickness and histology predict sentinel lymph node status. Am J Surg. 2001 Jan; 181(1):8-11.
    View in: PubMed
    Score: 0.010
  16. The effect of tamoxifen and cisplatin on the disease-free and overall survival of patients with high risk malignant melanoma. Br J Cancer. 2000 Jul; 83(1):16-21.
    View in: PubMed
    Score: 0.010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.